Compare TYGO & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TYGO | RCEL |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 102.5M |
| IPO Year | N/A | N/A |
| Metric | TYGO | RCEL |
|---|---|---|
| Price | $1.51 | $3.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $8.67 |
| AVG Volume (30 Days) | ★ 394.1K | 194.8K |
| Earning Date | 02-10-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $90,781,000.00 | $72,401,000.00 |
| Revenue This Year | $95.54 | $13.12 |
| Revenue Next Year | $21.30 | $27.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 97.41 | 20.59 |
| 52 Week Low | $0.58 | $3.25 |
| 52 Week High | $4.50 | $14.16 |
| Indicator | TYGO | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 42.19 | 41.31 |
| Support Level | $1.35 | $3.30 |
| Resistance Level | $1.73 | $3.71 |
| Average True Range (ATR) | 0.11 | 0.18 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 38.16 | 34.78 |
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.